Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cingulate Inc (CING)

Cingulate Inc (CING)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cingulate Inc 1901 W. 47TH PLACE KANSAS CITY KS 66205 USA

www.cingulate.com Employees: 13 P: 913-942-2300

Sector:

Medical

Description:

Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) drug delivery platform technology to build and advance a pipeline of pharmaceutical products. Cingulate Inc. is based in KANSAS CITY, Kan.

Key Statistics

Overview:

Market Capitalization, $K 41,774
Enterprise Value, $K 32,004
Shares Outstanding, K 7,446
Float, K 7,145
% Float 95.96%
Short Interest, K 324
Short Float 4.35%
Days to Cover 2.71
Short Volume Ratio 0.45
% of Insider Shareholders 4.04%
% of Institutional Shareholders 41.31%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,550 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,340 K
EBIT, $ -20,570 K
EBITDA, $ -19,920 K

Growth:

1-Year Return 23.95%
3-Year Return -97.41%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.35 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -3.62
EPS Growth vs. Prev Qtr -23.85%
EPS Growth vs. Prev Year 26.23%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/09/24

CING Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -394.49%
Return-on-Assets % -171.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.74
Book Value/Share 0.64
Interest Coverage -1.51
60-Month Beta -0.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar